Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$2.20 Mil
% of Total Estimate Gain
9.30%

Pioneer Core Equity Fund's Vertex Pharmaceuticals Inc Holding Summary

As of 2024-12-31, PIONEER SERIES TRUST XI held - shares of Vertex Pharmaceuticals Inc(VRTX), totaling N/A. This investment constitutes 0% of their stock portfolio, and PIONEER SERIES TRUST XI now holds 0% of the outstanding Vertex Pharmaceuticals Inc(VRTX) stock.

The initial trade took place in 2024Q1. And since then Pioneer Core Equity Fund has made 2 purchases of VRTX, at an average price of $424.01, for a total of 55,816.00 shares. In addition, there have been 1 sales at an average price of $463.43 for 55,816.00 shares. Based on historical transaction data and VRTX's current price of $478.11, Pioneer Core Equity Fund's estimated gain on his VRTX holdings is $2.20 Mil, reflecting a 9.30% gain to date.

Pioneer Core Equity Fund VRTX ($478.11) Holding Chart

Pioneer Core Equity Fund VRTX ($478.11) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1